Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Eisai Inc.
Condition: Endometrial Cancer
NCT01111461
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: few_sites_large_trial_signal
Stopped reason
Context when available
No stop reason available in the current public record.